About this trial
The aim of this study is to evaluate the role of the triglyceride-glucose (TyG) index as a predictive marker for insulin resistance in pre-diabetic patients with chronic kidney disease (CKD), and to investigate its potential utility as a simple, non-invasive alternative to traditional insulin resistance assessment methods.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged ≥18 years
Disqualifiers
Known type 1 or type 2 diabetes mellitus
Trial population
Adults aged ≥18 years with medical history free from renal dysfunction or with renal dysfunction (CKD stages 2\_5 based on KDIGO guidelines)
Trial design
Other
Cross-sectional
Treatments tested in this trial
Triglyceride-glucose index
Diagnostic testTriglyceride-glucose index calculation according to TyG index=In\[Triglycerides(mg/dl)×Fasting Glucose(mg/dl)/2\]
Treatment groups
Trial outcomes
Primary outcomes
Diagnostic performance of TyG index
Diagnostic performance of TyG index in predicting prediabetics and diabetic patients.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: